One-year mortality rate after discharge from hospital in relation to whether or not a confirmed myocardial infarction was developed

Int J Cardiol. 1991 Sep;32(3):381-8. doi: 10.1016/0167-5273(91)90302-6.

Abstract

Consecutive patients admitted to our hospital with suspected acute myocardial infarction during 21 months were prospectively evaluated. One-year mortality after discharge from hospital was related to whether or not an infarction developed (infarct versus non-infarct patients). Of patients discharged alive after developing an infarct, there was a mortality of 17% (n = 777) versus 12% (n = 1830) (P less than 0.001) for all patients not developing infarction. In a high risk group (any of the following: age greater than or equal to 75 years, previous history of myocardial infarction, diabetes mellitus or congestive heart failure) patients developing infarction had a mortality of 24% (n = 457) versus 17% (n = 1221) for those who did not (P less than 0.001). In a low risk group (none of the high risk criteria), the corresponding mortality was 8% (n = 316) for patients suffering infarction and 3% (n = 603) for those not having infarction (P less than 0.001). The difference in mortality between patients with and without infarction was most marked in women (21% vs 11%; P less than 0.01) and in hypertensives (25% vs 12%; P less than 0.001), but less marked in men (16% vs 13%; NS) and in patients without hypertension (13% vs 12%; NS). Among patients not suffering infarction, mortality was particularly high in those with previous congestive heart failure (23%) and diabetes mellitus (21%).

Publication types

  • Comparative Study

MeSH terms

  • Age Factors
  • Aged
  • Angina Pectoris / physiopathology
  • Angioplasty, Balloon, Coronary
  • Aspartate Aminotransferases / blood
  • Cause of Death
  • Coronary Artery Bypass
  • Electrocardiography
  • Female
  • Humans
  • Hypertension
  • Male
  • Multivariate Analysis
  • Myocardial Infarction / blood
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / mortality*
  • Myocardial Infarction / physiopathology
  • Patient Discharge*
  • Prognosis
  • Prospective Studies
  • Survival Rate
  • Sweden / epidemiology
  • Time Factors

Substances

  • Aspartate Aminotransferases